PathoAI Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

PathoAI General Information

Description

Provider of precision pathology solutions created to provide patients with accurate diagnoses and thereon avail them to effective treatments by using AI focused technology. The company uses AI-powered technology to the next generation automation that unlocks scientific insights through the intimate study of pathology samples, enabling doctors to effectively optimize patient outcomes.

Contact Information

Website
www.pathoai.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7th Floor, Building B, Number 258, Xiqin Street
  • Wuchang Street, Yuhang District
  • Hangzhou, Zhejiang
  • China
+86 400
Primary Industry
Business/Productivity Software
Other Industries
Diagnostic Equipment
Corporate Office
  • 7th Floor, Building B, Number 258, Xiqin Street
  • Wuchang Street, Yuhang District
  • Hangzhou, Zhejiang
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PathoAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 04-Aug-2025 Completed Generating Revenue
4. Early Stage VC 11-Nov-2024 Completed Generating Revenue
3. Early Stage VC 18-May-2023 Completed Generating Revenue
2. Secondary Transaction - Private 07-Nov-2022 Completed Startup
1. Seed Round 16-Mar-2021 Completed Startup
To view PathoAI’s complete valuation and funding history, request access »

PathoAI Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangzhou Hi-tech Investment Group Government Minority
Hangzhou Oufang Venture Capital Management Growth/Expansion Minority
Wanyuandian Investment Growth/Expansion Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
Taikun Fund Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

PathoAI FAQs

  • When was PathoAI founded?

    PathoAI was founded in 2021.

  • Where is PathoAI headquartered?

    PathoAI is headquartered in Hangzhou, China.

  • What industry is PathoAI in?

    PathoAI’s primary industry is Business/Productivity Software.

  • Is PathoAI a private or public company?

    PathoAI is a Private company.

  • What is PathoAI’s current revenue?

    The current revenue for PathoAI is .

  • Who are PathoAI’s investors?

    Guangzhou Hi-tech Investment Group, Hangzhou Oufang Venture Capital Management, Wanyuandian Investment, Hangzhou Tailong Venture Capital Partnership, and Taikun Fund are 5 of 6 investors who have invested in PathoAI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process